CA-TIGO
10.6.2024 15:01:29 CEST | Business Wire | Press release
Tigo Energy, Inc. (NASDAQ: TYGO), a leading provider of intelligent solar and energy software solutions, today announced it will unveil the new Tigo Installer Loyalty Program for residential PV installers in EMEA at Intersolar Europe 2024. As sustainable energy sources comprised 30% of all energy generated globally in 2023, with solar becoming an increasingly large contributor to that output, Tigo Energy is committed to supporting and invigorating the solar industry through initiatives like this loyalty program. Through exclusive benefits and solutions, the Tigo Installer Loyalty Program will recognize the dedication and professionalism of installers who choose Tigo solutions, further supporting their continued success and emphasizing the vitality of all members of the solar value chain to ensure the health of the solar industry.
Intersolar Europe 2024 attendees are invited to learn more about the training requirements and other qualifications for the Tigo Installer Loyalty Program by attending one of the scheduled program overview presentations. A comprehensive calendar of these introductory sessions is available on this page. Tigo will also offer the opportunity to enroll in the program at the event.
“We have worked with Tigo for years, and we are delighted to see this initiative come to installers here in the EMEA region,” said Michael Schmittinger, Managing Director at MMS Communication GmbH & Co. KG. “Our technicians and system designers have gained much from the Tigo Academy training resources, so I am happy to see this platform continue to be a focus in the loyalty program. We look forward to getting involved, learning, contributing, and continuing to build our solar business.”
“As the solar industry converges on Intersolar Europe in Munich, we are excited to welcome PV professionals into our new Installer Loyalty Program, introduce our latest MLPE products, and showcase the power of Tigo software to enhance system performance,” said Mirko Bindi, Senior VP Sales EMEA & MD Europe at Tigo Energy. “At Tigo, we are building the technology and service-oriented culture to empower all solar installers to embrace continuous improvement and a dedication to quality across the entire solar value chain. Underpinning these initiatives is a constantly evolving set of software capabilities that are quickly becoming the catalyst to achieving these goals, and we are very excited to showcase all of this at Intersolar Europe this year.”
With three tiers of participation, the Tigo Installer Loyalty Program offers progressively more valuable benefits for participants, including co-branding, homeowner sales leads, customized collateral, and promotion via the Tigo newsletter. Program participants will also be able to gain early access to new product developments, including participation in Tigo installer council sessions to provide the Company feedback. In addition to the new loyalty program, Tigo will showcase the Tigo EI Residential Solution, now extended to e-mobility with the GO EV Charger. The Company will also showcase the recently-released TS4-X, a new family of Flex MLPE solutions for high-power solar modules, providing safety, monitoring, optimization, and a new Multi-Factor Rapid Shutdown (MFRS) capability for energy-critical applications. Remaining true to the Company’s commitment to open architectures and broad compatibility, products within the TS4-X family work with the largest selection of third-party inverters, supporting the latest high-power and bifacial solar modules, up to 800W.
“We have carried Tigo products in our portfolio for more than ten years, and the new high-power TS4-X optimizers are an outstanding addition to our product range,” said Justin Gann, marketing manager for products and suppliers at Krannich Group GmbH. “We will exhibit the entire range of Tigo solutions at Intersolar this year because these products have proven to be very reliable and of high quality, and they are becoming increasingly popular with our customers. We are delighted to have a high-quality professional provider like Tigo in our portfolio.”
Additionally, Tigo will hold two Technical Coffee Breaks, during which solar professionals can review the specifications of the new TS4-X product family and the EI Residential Solution with members of the Tigo product team. Participation in the Technical Coffee Breaks is free, and the sessions will be held on June 19th and 20th at 16:00 at the Tigo booth (#B4.239).
Please visit the scheduling page here to view a complete list of partners displaying Tigo solutions, register for an Installer Loyalty Program presentation, or schedule a meeting with a member of the Tigo team. To inquire about the Installer Loyalty Program, visit here.
About Tigo Energy
Founded in 2007, Tigo is a worldwide leader in the development and manufacture of smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Tigo combines its Flex MLPE (Module Level Power Electronics) and solar optimizer technology with intelligent, cloud-based software capabilities for advanced energy monitoring and control. Tigo MLPE products maximize performance, enable real-time energy monitoring, and provide code-required rapid shutdown at the module level. The company also develops and manufactures products such as inverters and battery storage systems for the residential solar-plus-storage market. For more information, please visit www.tigoenergy.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240610982934/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 16:37:00 CEST | Press release
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory standardsFDA grants Compass NDA rolling submission and review request, based on Phase 3 dataCNPV awarded for COMP360, Compass’ proprietary formulation of synthetic psilocybin, for treatment-resistant depression (TRD)CNPV further accelerates momentum and Compass is confident and ready to deliver for patients Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom